In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA accounting for FY 1996 spending criticized by Sen. Cochran at May 1 hearing.

This article was originally published in The Tan Sheet

Executive Summary

FDA ACCOUNTING OF FY 1996 SPENDING CRITICIZED by Sen. Thad Cochran (R-Miss.) at a May 1 Senate Appropriations/Agriculture Subcommittee hearing. In requesting an amendment to FDA's FY 1998 budget detailing rent and other office expenses, the subcommittee chairman chastised the agency for giving Congress the "run around" when it inquires how funds are being allocated and for its "callous disregard" of Congress' views when it distributes its monies.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts